Cargando…

ChAdOx1 nCoV-19 effectiveness during an unprecedented surge in SARS COV-2 infections

Detalles Bibliográficos
Autores principales:	Satwik, Ruma, Satwik, Ambarish, Katoch, Satendra, Saluja, Satish
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Federation of Internal Medicine. Published by Elsevier B.V. 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8364816/ https://www.ncbi.nlm.nih.gov/pubmed/34419309 http://dx.doi.org/10.1016/j.ejim.2021.08.005

Ejemplares similares

Postvaccinal Encephalitis after ChAdOx1 nCov‐19
por: Zuhorn, Frédéric, et al.
Publicado: (2021)

Thromboses of major arteries and ChAdOx1 nCov-19 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2021)

Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination
por: Greinacher, Andreas, et al.
Publicado: (2021)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Lodge, Archie
Publicado: (2020)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2
por: Chauhan, Anil, et al.
Publicado: (2020)

Polyarthralgia and Myalgia Syndrome after ChAdOx1 nCOV-19 Vaccination
por: Hyun, Hakjun, et al.
Publicado: (2021)

Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccination
por: Öcal, Osman, et al.
Publicado: (2021)

Widespread Arterial Thrombosis after ChAdOx1 nCov-19 Vaccination
por: Berlot, Giorgio, et al.
Publicado: (2022)

Venous sinus thrombosis following vaccination with ChAdOx1 nCov-19()
por: Morales Varas, G., et al.
Publicado: (2022)

LGI-1 encephalopathy following ChAdOx1 nCov-19 vaccination
por: Garibashvili, Tamara, et al.
Publicado: (2022)

Process- and product-related impurities in the ChAdOx1 nCov-19 vaccine
por: Krutzke, Lea, et al.
Publicado: (2022)

ChAdOx1 nCoV-19 vaccine for SARS-CoV-2 – Authors' reply
por: Voysey, Merryn, et al.
Publicado: (2020)

DIC-Like Syndrome Following Administration of ChAdOx1 nCov-19 Vaccination
por: Casucci, Gerardo, et al.
Publicado: (2021)

Cerebral venous sinus thrombosis secondary to ChAdOx-1 nCov-19 vaccine
por: Atta, Syed Noman, et al.
Publicado: (2021)

Depression following ChAdOx1-S/nCoV-19 vaccine
por: Uvais, N.A.
Publicado: (2022)

Successful treatment of thromboses of major arteries after ChAdOx1 nCov-19 vaccination
por: Goereci, Yasemin, et al.
Publicado: (2021)

Safety Warning for ChAdOx1 nCov-19 Vaccine in Patients with Sickle Cell Disease
por: Alkindi, S., et al.
Publicado: (2021)

Trombosis de senos venosos tras vacunación con ChAdOx1 nCov-19
por: Morales Varas, G., et al.
Publicado: (2022)

Effectiveness of ChAdOx1 nCOV-19 Vaccine: Experience of a tertiary care institute
por: Bobdey, Saurabh, et al.
Publicado: (2021)

Effectiveness of ChAdOx1 nCOV-19 Vaccine: Experience of a tertiary care institute
por: Koshy, George
Publicado: (2022)

Polymyalgia Rheumatica After ChAdOx1 nCov-19 Vaccine: A Case Report
por: Lourenço, Carolina, et al.
Publicado: (2022)

Reversible radiculomyelitis after ChAdOx1 nCoV-19 vaccination
por: Spataro, Rossella, et al.
Publicado: (2022)

Thrombosis and Thrombocytopenia after ChAdOx1 nCoV-19 Vaccination
por: Schultz, Nina H., et al.
Publicado: (2021)

Effectiveness of ChAdOx1 nCoV-19 vaccine during the delta (B.1.617.2) variant surge in India
por: Chakrabarti, Sasanka, et al.
Publicado: (2022)

Comparative analysis of ChAdOx1 nCoV-19 and Ad26.COV2.S SARS-CoV-2 vector vaccines
por: Michalik, Stephan, et al.
Publicado: (2022)

ChAdOx1 nCoV-19 vaccination prevents SARS-CoV-2 pneumonia in rhesus macaques
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

ChAdOx1 nCoV-19 vaccine prevents SARS-CoV-2 pneumonia in rhesus macaques
por: van Doremalen, Neeltje, et al.
Publicado: (2020)

ChAdOx1 nCov-19 vaccine-induced thrombotic thrombocytopenic purpura successfully treated with plasmapheresis
por: Wang, Yen-Ching, et al.
Publicado: (2021)

Platelet activation and modulation in thrombosis with thrombocytopenia syndrome associated with ChAdOx1 nCov-19 vaccine
por: Scavone, Mariangela, et al.
Publicado: (2021)

Acute Arterial Occlusion Following ChAdOx1 nCov-19 (Oxford–AstraZeneca) Vaccination
por: Ali, Azhar, et al.
Publicado: (2022)

AZD1222 (ChAdOx1 nCov-19): A Single-Dose biodistribution study in mice
por: Stebbings, Richard, et al.
Publicado: (2022)

Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19)
por: Paulsen, Finn-Ole, et al.
Publicado: (2021)

Accelerated Hypertension and Intracerebral Haemorrhage Following First Dose of ChAdOx1-nCOV-19 Vaccination
por: Pandey, Shweta, et al.
Publicado: (2022)

Thrombotic thrombocytopenic purpura following ChAdOx1 nCov-19 vaccination: A case report
por: Shateri Amiri, Bahareh, et al.
Publicado: (2023)

Stability of Chimpanzee Adenovirus Vectored Vaccines (ChAdOx1 and ChAdOx2) in Liquid and Lyophilised Formulations
por: Berg, Adam, et al.
Publicado: (2021)

Lyophilization to enable distribution of ChAdOx1 and ChAdOx2 adenovirus-vectored vaccines without refrigeration
por: Zhang, Cheng, et al.
Publicado: (2023)

Longer intervals and extra doses of ChAdOx1 nCoV-19 vaccine
por: Rogawski McQuade, Elizabeth T, et al.
Publicado: (2021)

Heterologous ChAdOx1 nCoV-19 and mRNA-1273 Vaccination
por: Normark, Johan, et al.
Publicado: (2021)

Takotsubo (stress) cardiomyopathy after ChAdOx1 nCoV-19 vaccination
por: Crane, Phillip, et al.
Publicado: (2021)

Thrombotic thrombocytopenic purpura after ChAdOx1 nCoV-19 vaccine
por: Lee, Hui Ping, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_orimo0g60rq26g5j190vppl5sf